Nkarta, Inc. (NKTX)
After hours:
Chart Events
Performance Outlook
| Previous Close | 12.32 |
| Open | 12.54 |
| Bid | 12.50 x 900 |
| Ask | 14.70 x 1000 |
| Day's Range | 12.19 - 13.24 |
| 52 Week Range | 7.55 - 40.64 |
| Volume | |
| Avg. Volume | 3,219,372 |
| Market Cap | 637.969M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.82 |
| Earnings Date | Aug 10, 2022 - Aug 15, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 46.50 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for NKTX
Related Research
- Nkarta, Inc.Daily – Vickers Top Buyers & Sellers for 05/02/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.RatingFair ValueEconomic Moat2 months agoArgus Research
- Simply Wall St.
What Is The Ownership Structure Like For Nkarta, Inc. (NASDAQ:NKTX)?
A look at the shareholders of Nkarta, Inc. ( NASDAQ:NKTX ) can tell us which group is most powerful. Large companies...
- Zacks
Wall Street Analysts Predict a 209% Upside in Nkarta, Inc. (NKTX): Here's What You Should Know
The consensus price target hints at a 209.4% upside potential for Nkarta, Inc. (NKTX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- GlobeNewswire
Nkarta to Participate at Upcoming Investor Conference
SOUTH SAN FRANCISCO, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today announced its participation at an upcoming investor conference: Cowen 3rd Annual Oncology Innovation SummitJune 2, 202211:00 a.m. ET – fireside chat A simultaneous webcast of the event will be available on the Investors section of Nkarta’s website, www.nkartatx.com, and a replay will be archived on t
